268 related articles for article (PubMed ID: 21229382)
21. Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.
Wei GZ; Zhu MY; Wang F; Zhao YG; Li SS; Liu TY; Luo Y; Tang WR
Z Gerontol Geriatr; 2016 Jan; 49(1):24-31. PubMed ID: 25962362
[TBL] [Abstract][Full Text] [Related]
22. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
23. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis.
Liu C; Liu L
Tumour Biol; 2011 Dec; 32(6):1233-40. PubMed ID: 21887553
[TBL] [Abstract][Full Text] [Related]
25. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.
Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D
Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968
[TBL] [Abstract][Full Text] [Related]
26. Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in Chinese Han population.
Wang H; Li L; Ding L; Zhang Z; Pu C
J Investig Med; 2012 Mar; 60(3):592-7. PubMed ID: 22367101
[TBL] [Abstract][Full Text] [Related]
27. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome.
Kordi-Tamandani DM; Hashemi M; Sharifi N; Kaykhaei MA; Torkamanzehi A
Mol Biol Rep; 2012 Feb; 39(2):937-43. PubMed ID: 21573798
[TBL] [Abstract][Full Text] [Related]
28. Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
Bae SC; Lee YH
Clin Rheumatol; 2019 Aug; 38(8):2141-2149. PubMed ID: 30868319
[TBL] [Abstract][Full Text] [Related]
29. The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies.
Pan X; Huang L; Li M; Mo D; Liang Y; Liu Z; Huang Z; Huang L; Liu J; Zhu B
Biomed Res Int; 2019; 2019():5897505. PubMed ID: 31467900
[TBL] [Abstract][Full Text] [Related]
30. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
[TBL] [Abstract][Full Text] [Related]
31. Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes.
Mahrooz A; Hashemi-Soteh MB; Heydari M; Boorank R; Ramazani F; Mahmoudi A; Kianmehr A; Alizadeh A
Clin Chim Acta; 2018 Sep; 484():40-46. PubMed ID: 29782842
[TBL] [Abstract][Full Text] [Related]
32. Association of PON1-L55M Genetic Variation and Breast Cancer Risk: A Case-Control Trial.
Farmohammadi A; Momeni A; Bahmani B; Ghorbani H; Ramzanpour R
Asian Pac J Cancer Prev; 2020 Jan; 21(1):255-258. PubMed ID: 31983193
[TBL] [Abstract][Full Text] [Related]
33. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
Fekih O; Triki S; Rejeb J; Neffati F; Douki W; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
Endokrynol Pol; 2017; 68(1):35-41. PubMed ID: 26884296
[TBL] [Abstract][Full Text] [Related]
34. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
[TBL] [Abstract][Full Text] [Related]
35. The Paraoxonase 1 Gene c.-108C>T SNP in the Promoter Is Associated with Risk for Glioma in Mexican Patients, but Not the p.L55M or p.Q192R Polymorphisms in the Coding Region.
González-Herrera L; Gamas-Trujillo PA; Medina-Escobedo G; Oaxaca-Castillo D; Pérez-Mendoza G; Williams-Jacquez D; Canto-Cetina T; Vargas-García RD
Genet Test Mol Biomarkers; 2015 Sep; 19(9):494-9. PubMed ID: 26154629
[TBL] [Abstract][Full Text] [Related]
36. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population.
Arca M; Ombres D; Montali A; Campagna F; Mangieri E; Tanzilli G; Campa PP; Ricci G; Verna R; Pannitteri G
Eur J Clin Invest; 2002 Jan; 32(1):9-15. PubMed ID: 11851721
[TBL] [Abstract][Full Text] [Related]
37. Association Between PON1 (L55M and Q192R) Genetic Polymorphism and Recurrent Pregnancy Loss in North Indian Women Exposed to Pesticides.
Jaiswar SP; Priyadarshini A; Singh A; Ahmad MK; Deo S; Sankhwar P
Rev Bras Ginecol Obstet; 2021 Nov; 43(11):805-810. PubMed ID: 34872137
[TBL] [Abstract][Full Text] [Related]
38. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
[TBL] [Abstract][Full Text] [Related]
39. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
40. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.
de Aguiar Gonçalves BA; Vasconcelos GM; Thuler LC; Andrade C; Faro A; Pombo-de-Oliveira MS; ; Emerenciano M; de Camargo B; Bernstain L; Neves CC; Agareno JM; de Carvalho LM; Araújo FN; de Brito NP; Magalhães IQ; Cordoba JC; Pimenta F; Gadelha A; Cartaxo E; Basegio RM; Mnayarji A; Souza MS; Arencibia A; Melaragno R; Cóser VM; Lafayete TC; Koifman S
Cancer Causes Control; 2012 Nov; 23(11):1811-9. PubMed ID: 22976839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
